Nutritional support of the cancer patient: issues and dilemmas.
Malnutrition in cancer patients results from multifactorial events and is associated with an alteration of quality of life and a reduced survival. A simple nutritional assessment program and early counselling by a dietitian are essential to guide nutritional support and to alert the physician to the need for enteral (EN) or parenteral nutrition (PN). A daily intake of 20-35 kcal/kg, with a balanced contribution of glucose and lipids, and of 0.2-0.35 g nitrogen/kg is recommended both for EN and PN, with an adequate provision of electrolytes, trace elements and vitamins. EN, always preferable for patients with an intact digestive tract, and PN are both safe and effective methods of administering nutrients. The general results in clinical practice suggest no tumor growth during nutritional support. The indiscriminate use of conventional EN and PN is not indicated in well-nourished cancer patients or in patients with mild malnutrition. EN or PN is not clinically efficacious for patients treated with chemotherapy or radiotherapy, unless there are prolonged periods of GI toxicity, as in the case of bone marrow transplant patients. Severely malnourished cancer patients undergoing major visceral surgery may benefit from perioperative nutritional support, preferably via enteral access. Nutritional support in palliative care should be based on the potential risks and benefits of EN and PN, and on the patient's and family's wishes. Research is currently directed toward the impact of nutritional pharmacology on the clinical outcome of cancer patients. Glutamine-supplemented PN is probably beneficial in bone marrow transplant patients. Immune diets are likely to reduce the rate of infectious complications and the length of hospital stay after GI surgery. Further studies are needed to determine the efficacy of such novel approaches in specific populations of cancer patients, and should also address the question of the overall cost-benefit ratio of nutritional pharmacology, and the effect of nutritional support on length and quality of life.
Nitenberg
G
G
Intensive Care Unit, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805, Villejuif, France. nitenber@igr.fr
Raynard
B
B
D002100:Cachexia / Q000178:diet therapy / Q000209:etiology / Q000523:psychology; D019587:Dietary Supplements; D005247:Feeding Behavior; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000178:diet therapy* / Q000503:physiopathology; D015596:Nutrition Assessment; D009748:Nutrition Disorders / Q000178:diet therapy / Q000209:etiology / Q000523:psychology; D018529:Nutritional Support / Q000379:methods* / Q000523:psychology / Q000706:statistics & numerical data